Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Bitton

Showing results (91-100 of 200) with videos related to

Pageof 20
Sort By:
Journal of Clinical Medicine|August 12, 2022
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisGustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, et al.
Cellular Signalling|February 26, 2022
IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammationVirginie Mercier, Gabrielle Boucher, Dominic Devost, et al.
Plos Genetics|September 26, 2022
Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel DiseasesMohamad Karaky, Gabrielle Boucher, Saraï Mola, et al.
European Journal of Human Genetics : EJHG|January 5, 2006
Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosisPhilip L De Jager, Stephen Sawcer, Alicja Waliszewska, et al.
Inflammatory Bowel Diseases|September 19, 2025
Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative ColitisGustavo Drügg Hahn, Peter Laszlo Lakatos, Chelsea Maedler-Kron, et al.
Inflammatory Bowel Diseases|December 18, 2014
Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkersUri Kopylov, Artur Nemeth, Anastasios Koulaouzidis, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in SeniorsGeoffrey C Nguyen, Laura E Targownik, Harminder Singh, et al.
Inflammatory Bowel Diseases|August 2, 2022
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral CentersPauline Rivière, Caitlyn Kanters, Gauthier Pellet, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD CentreLorant Gonczi, Zsuzsanna Kurti, Christine Verdon, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 29, 2018
Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinicJason Reinglas, Sophie Restellini, Lorant Gonczi, et al.
Pageof 20

Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Journal of Clinical Medicine|August 12, 2022
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisGustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, et al.
Cellular Signalling|February 26, 2022
IBD-associated G protein-coupled receptor 65 variant compromises signalling and impairs key functions involved in inflammationVirginie Mercier, Gabrielle Boucher, Dominic Devost, et al.
Plos Genetics|September 26, 2022
Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel DiseasesMohamad Karaky, Gabrielle Boucher, Saraï Mola, et al.
European Journal of Human Genetics : EJHG|January 5, 2006
Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosisPhilip L De Jager, Stephen Sawcer, Alicja Waliszewska, et al.
Inflammatory Bowel Diseases|September 19, 2025
Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative ColitisGustavo Drügg Hahn, Peter Laszlo Lakatos, Chelsea Maedler-Kron, et al.
Inflammatory Bowel Diseases|December 18, 2014
Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkersUri Kopylov, Artur Nemeth, Anastasios Koulaouzidis, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in SeniorsGeoffrey C Nguyen, Laura E Targownik, Harminder Singh, et al.
Inflammatory Bowel Diseases|August 2, 2022
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral CentersPauline Rivière, Caitlyn Kanters, Gauthier Pellet, et al.
Journal of Crohn'S & Colitis|February 23, 2019
Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD CentreLorant Gonczi, Zsuzsanna Kurti, Christine Verdon, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 29, 2018
Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinicJason Reinglas, Sophie Restellini, Lorant Gonczi, et al.
Pageof 20